103 related articles for article (PubMed ID: 8420881)
1. Continuous low dose rate brachytherapy with high activity iodine-125 seeds in the management of meningiomas.
Kumar PP; Patil AA; Leibrock LG; Chu WK; Syh HW; McCaul GF; Reeves MA
Int J Radiat Oncol Biol Phys; 1993 Jan; 25(2):325-8. PubMed ID: 8420881
[TBL] [Abstract][Full Text] [Related]
2. Brachytherapy: a viable alternative in the management of basal meningiomas.
Kumar PP; Patil AA; Leibrock LG; Chu WK; Syh J; McCaul GF; Reeves MA
Neurosurgery; 1991 Nov; 29(5):676-80. PubMed ID: 1961396
[TBL] [Abstract][Full Text] [Related]
3. Role of brachytherapy in the management of the skull base meningioma. Treatment of skull base meningiomas.
Kumar PP; Patil AA; Syh HW; Chu WK; Reeves MA
Cancer; 1993 Jun; 71(11):3726-31. PubMed ID: 8490923
[TBL] [Abstract][Full Text] [Related]
4. Brachytherapy for intracranial meningioma using a permanently implanted iodine-125 seed.
Obasi PC; Barnett GH; Suh JH
Stereotact Funct Neurosurg; 2002; 79(1):33-43. PubMed ID: 12677103
[TBL] [Abstract][Full Text] [Related]
5. Interstitial radiotherapy of 25 parasellar/clival meningiomas and 19 meningiomas in the elderly. Analysis of short-term tolerance and responses.
Vuorinen V; Heikkonen J; Brander A; Setälä K; Sane T; Randell T; Paetau A; Pohjola J; Mäntylä M; Jääskeläinen J
Acta Neurochir (Wien); 1996; 138(5):495-508. PubMed ID: 8800323
[TBL] [Abstract][Full Text] [Related]
6. Permanent high-activity iodine-125 in the management of petroclival meningiomas: case reports.
Kumar PP; Good RR; Patil AA; Leibrock LG
Neurosurgery; 1989 Sep; 25(3):436-41; discussion 441-2. PubMed ID: 2671788
[TBL] [Abstract][Full Text] [Related]
7. Surgical Resection and Interstitial Iodine-125 Brachytherapy for High-Grade Meningiomas: A 25-Year Series.
Magill ST; Lau D; Raleigh DR; Sneed PK; Fogh SE; McDermott MW
Neurosurgery; 2017 Mar; 80(3):409-416. PubMed ID: 27258768
[TBL] [Abstract][Full Text] [Related]
8. Brachytherapy for meningiomas.
Magill ST; Schwartz TH; Theodosopoulos PV; McDermott MW
Handb Clin Neurol; 2020; 170():303-307. PubMed ID: 32586503
[TBL] [Abstract][Full Text] [Related]
9. Surgical resection and permanent brachytherapy for recurrent atypical and malignant meningioma.
Ware ML; Larson DA; Sneed PK; Wara WW; McDermott MW
Neurosurgery; 2004 Jan; 54(1):55-63; discussion 63-4. PubMed ID: 14683541
[TBL] [Abstract][Full Text] [Related]
10. A new method for treatment of unresectable, recurrent brain tumors with single permanent high-activity 125iodine brachytherapy.
Kumar PP; Good RR; Jones EO; Hahn FJ; McCaul GF; Gallagher TF; Cox TA; Leibrock LG; Skultety MF
Radiat Med; 1986; 4(1):12-20. PubMed ID: 3775067
[TBL] [Abstract][Full Text] [Related]
11. Brachytherapy as an Adjuvant for Recurrent Atypical and Malignant Meningiomas.
Koch MJ; Agarwalla PK; Royce TJ; Shih HA; Oh K; Niemierko A; Mauceri TC; Curry WT; Barker FG; Loeffler JS
Neurosurgery; 2019 Nov; 85(5):E910-E916. PubMed ID: 31329941
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.
Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH
Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of fractionated stereotactic radiotherapy for intracranial skull base benign meningiomas in single institution.
Onodera S; Aoyama H; Katoh N; Taguchi H; Yasuda K; Yoshida D; Surtherland K; Suzuki R; Ishikawa M; Gerard B; Terasaka S; Shirato H
Jpn J Clin Oncol; 2011 Apr; 41(4):462-8. PubMed ID: 21177777
[TBL] [Abstract][Full Text] [Related]
14. Volumetric response of intracranial meningioma after photon or particle irradiation.
Mozes P; Dittmar JO; Habermehl D; Tonndorf-Martini E; Hideghety K; Dittmar A; Debus J; Combs SE
Acta Oncol; 2017 Mar; 56(3):431-437. PubMed ID: 27911139
[TBL] [Abstract][Full Text] [Related]
15. Brachytherapy in the treatment of recurrent aggressive falcine meningiomas.
Abou Al-Shaar H; Almefty KK; Abolfotoh M; Arvold ND; Devlin PM; Reardon DA; Loeffler JS; Al-Mefty O
J Neurooncol; 2015 Sep; 124(3):515-22. PubMed ID: 26253325
[TBL] [Abstract][Full Text] [Related]
16. Brachytherapy of recurrent tumors of the skull base and spine with iodine-125 sources.
Gutin PH; Leibel SA; Hosobuchi Y; Crumley RL; Edwards MS; Wilson CB; Lamb S; Weaver KA
Neurosurgery; 1987 Jun; 20(6):938-45. PubMed ID: 3614575
[TBL] [Abstract][Full Text] [Related]
17. Large volume re-irradiation for recurrent meningioma with pulsed reduced dose rate radiotherapy.
Witt JS; Musunuru HB; Bayliss RA; Howard SP
J Neurooncol; 2019 Jan; 141(1):103-109. PubMed ID: 30392090
[TBL] [Abstract][Full Text] [Related]
18. CT-guided implantation of (125)I seeds (permanent brachytherapy) for metastatic tumors of the hepatic portal system: Effectiveness and safety in 13 patients.
Li J; Xie Q; Wang W; Hua Y; Cheng Y; Li L; Zhu X
Brachytherapy; 2016; 15(2):224-30. PubMed ID: 26832671
[TBL] [Abstract][Full Text] [Related]
19. Intensity-modulated radiation therapy (IMRT) for newly diagnosed and recurrent intracranial meningiomas: preliminary results.
Sajja R; Barnett GH; Lee SY; Harnisch G; Stevens GH; Lee J; Suh JH
Technol Cancer Res Treat; 2005 Dec; 4(6):675-82. PubMed ID: 16292888
[TBL] [Abstract][Full Text] [Related]
20. Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas.
Weber DC; Lomax AJ; Rutz HP; Stadelmann O; Egger E; Timmermann B; Pedroni ES; Verwey J; Miralbell R; Goitein G;
Radiother Oncol; 2004 Jun; 71(3):251-8. PubMed ID: 15172139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
